Activity-based protein profiling identifies dehydrodiisoeugenol as a novel ferroptosis inhibitor targeting ACSL4 to attenuate cisplatin-induced acute kidney injury
Chinese Chemical Letters · 2026-04 · 112793
DOI: 10.1016/j.cclet.2026.112793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-04. Verfasst von Fan Wu und 10 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wu, F., Zhai, Z., Sheng, G., Jia, B., Liu, Z., Kong, W., Jia, B., Wang, S., Lai, C., Zhang, Y., & Du, P. (2026). Activity-based protein profiling identifies dehydrodiisoeugenol as a novel ferroptosis inhibitor targeting ACSL4 to attenuate cisplatin-induced acute kidney injury. Chinese Chemical Letters, 112793. https://doi.org/10.1016/j.cclet.2026.112793
Vancouver
Wu F, Zhai Z, Sheng G, Jia B, Liu Z, Kong W, et al. Activity-based protein profiling identifies dehydrodiisoeugenol as a novel ferroptosis inhibitor targeting ACSL4 to attenuate cisplatin-induced acute kidney injury. Chinese Chemical Letters. 2026:112793. doi:10.1016/j.cclet.2026.112793
BibTeX
@article{Wu2026,
author = {Wu, Fan and Zhai, Zhao and Sheng, Guoli and Jia, Bin and Liu, Zehua and Kong, Weiya and Jia, Bolin and Wang, Shuo and Lai, Caiyong and Zhang, Yong and Du, Peng},
title = {Activity-based protein profiling identifies dehydrodiisoeugenol as a novel ferroptosis inhibitor targeting ACSL4 to attenuate cisplatin-induced acute kidney injury},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {112793},
doi = {10.1016/j.cclet.2026.112793}
}
EUVIMED